Skip to main content

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Investor Lawsuit Over Alleged Wrgondoing In Acquisition By Takeda Pharmaceutical Company Limited Filed

  • If you purchased shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 6, 2017 (Shareholders Foundation) - An investor who currently holds shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), filed a lawsuit in effort to halt the proposed takeover of Ariad Pharmaceuticals, Inc. by Takeda Pharmaceutical Company Limited for $24.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:ARIA stockholders ...

You must register (for free) or login to view the entire case.